Biotricity Inc.(BTCY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BTCY Biotricity Inc.

Market Closed 12-20 16:00:00 EST Delay

{"stockData":{"symbol":"BTCY","market":"US","secType":"STK","nameCN":"Biotricity Inc.","latestPrice":0.28,"timestamp":1734728400000,"preClose":0.2919,"halted":0,"volume":201580,"delay":15,"floatShares":16027771,"shares":24555114,"eps":-1.766448,"marketStatus":"Market Closed","change":-0.0119,"latestTime":"12-20 16:00:00 EST Delay","open":0.2922,"high":0.2922,"low":0.23,"amount":52417.029290000006,"amplitude":0.213087,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.766448,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.2919,"volumeRatio":2.9612849948313613},"requestUrl":"/m/hq/s/BTCY/tweets","defaultTab":"tweets","newsList":[{"id":"2488910671","title":"BRIEF-Biotricity Achieves Positive Free Cash Flow Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2488910671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488910671?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:47","pubTimestamp":1733233677,"startTime":"0","endTime":"0","summary":"BRIEF-Biotricity Achieves Positive Free Cash Flow MilestoneDec 3 (Reuters) - Biotricity Inc BTCY.PK:BIOTRICITY ACHIEVES POSITIVE FREE CASH FLOW MILESTONESource text: ID:nPnZlQCpaFurther company coverage: BTCY.PK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA7P4WH6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","BTCY"],"gpt_icon":0},{"id":"2488175912","title":"Biotricity Achieves Positive Free Cash Flow Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2488175912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488175912?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:15","pubTimestamp":1733231702,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA7P4WH6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BTCY","BK4167"],"gpt_icon":0},{"id":"2484062824","title":"H.C. Wainwright Reaffirms Their Hold Rating on Biotricity (BTCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2484062824","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484062824?lang=en_us&edition=fundamental","pubTime":"2024-11-18 19:17","pubTimestamp":1731928672,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Kevin Dede maintained a Hold rating on Biotricity (BTCY – Research Report) today. The company’s shares closed last Friday a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-hold-rating-on-biotricity-btcy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-hold-rating-on-biotricity-btcy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BTCmain","BTC","BTCY","XBTmain"],"gpt_icon":0},{"id":"2483337373","title":"Biotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2483337373","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483337373?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:15","pubTimestamp":1731676500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nTUA8GPXK9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BTCY","BK4167"],"gpt_icon":0},{"id":"2476432896","title":"SWK Holdings Provides Portfolio Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2476432896","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476432896?lang=en_us&edition=fundamental","pubTime":"2024-10-18 04:15","pubTimestamp":1729196100,"startTime":"0","endTime":"0","summary":"Company Announces Q3 Earnings and Conference Call Dates. DALLAS, TX / ACCESSWIRE / October 17, 2024 / SWK Holdings Corporation  , a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a portfolio update and announced the anticipated date of the third quarter earnings and conference call schedule.The Company intends to issue their third quarter financials after market close on November 14, 2024, and will host a conference call at 9:00 a.m. Central Time on November 15, 2024, to discuss the company's financial results for the quarter. Call details will be available in the quarterly results news release.In September, SWK expanded its existing credit facility with Eton by $25.7M to $30.0M. The extension will support Eton's acquisition of Increlex, which is expected to close near year-end 2024.In September, Epica International, Inc. repaid the outstanding term loan principal balance of $8.3M as well as accrued interest an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/swk-holdings-provides-portfolio-201500714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU0225284248.USD","LU0321505868.SGD","LU0225771236.USD","SWK","BTCY","EDC","BK4585","BK4566","BK4161","DERM","BK4139","BK4167","LU0985481810.HKD","SWKH","ELUT","LU0306806265.USD","ETON","LU0306807586.USD","LU0321505439.SGD"],"gpt_icon":0},{"id":"2472711937","title":"Biotricity reaches EBITDA positive on go-forward cash basis","url":"https://stock-news.laohu8.com/highlight/detail?id=2472711937","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472711937?lang=en_us&edition=fundamental","pubTime":"2024-10-04 18:04","pubTimestamp":1728036276,"startTime":"0","endTime":"0","summary":"Biotricity (OTC:BTCY) said it has achieved EBITDA positive on a go-forward cash basis.\nThe firm added it is now on an accelerated trajectory to profitability boosted by growing revenues from sales and strategic partnerships, and improving margins.\nShares were down 13.2% in premarket trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4156361-biotricity-reaches-ebitda-positive-on-go-forward-cash-basis","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BTCY","BK4167"],"gpt_icon":0},{"id":"2454347515","title":"LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV","url":"https://stock-news.laohu8.com/highlight/detail?id=2454347515","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454347515?lang=en_us&edition=fundamental","pubTime":"2024-07-26 21:00","pubTimestamp":1721998800,"startTime":"0","endTime":"0","summary":"ORLANDO, FL / ACCESSWIRE / July 26, 2024 / RedChip Companies will air interviews with LOBO EV Technologies Ltd.  and Biotricity, Inc.  on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV, this Saturday, July 27, at 7 p.m. Eastern Time . Bloomberg TV is available in an estimated 73 million homes across the U.S.LOBO is an innovative designer, developer, manufacturer and seller of e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons. LOBO also provides automobile information and entertainment software development and design services to customers. Leveraging its cutting-edge technologies","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_CGqlr_T72W08fVAOQ9fAw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/e0cfc5cb7f676adb9179054efe7f38b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_CGqlr_T72W08fVAOQ9fAw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/e0cfc5cb7f676adb9179054efe7f38b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lobo-ev-nexalin-interviews-air-130000142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4100","CAGR","BK4159","03160","TM","BK4099","BK4144","BK4561","BTCY","BK4555","BK4187","AIRI","BK4091","BK4588","BK4590","BK4585","TV","LOBO","ET","BK4581"],"gpt_icon":0},{"id":"2453653765","title":"Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud","url":"https://stock-news.laohu8.com/highlight/detail?id=2453653765","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2453653765?lang=en_us&edition=fundamental","pubTime":"2024-07-22 19:00","pubTimestamp":1721646000,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, CA / ACCESSWIRE / July 22, 2024 / Biotricity Inc. , a Technology-as-a-Service  company operating in the remote cardiac monitor sector of consumer healthcare, today announced ongoing improvements in operational efficiency, scalability and margin performance driven by the latest enhancements to the company's proprietary AI Cloud platform.The latest version of Biotricity's AI Cloud has improved the company's tech stack efficiency by 20%, which is expected to result in a topline margin improvement of 200 to 300 basis points  in the coming quarters. The next version of the AI Cloud, currently under development, is anticipated to enhance the tech stack by another 20%, contributing to an additional margin improvement of 100 to 200 basis points . These across-the-board improvements are accelerating Biotricity's path to breakeven and achieving positive cash flow.Any statements contained in this press release that do not describe historical facts may constitute forward-looking stat","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/S7NoY4Fk4Y8XZNrkFk00fA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/6602915a7edb69618135560a83aca165","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/S7NoY4Fk4Y8XZNrkFk00fA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/6602915a7edb69618135560a83aca165"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotricity-announces-continued-margin-improvement-110000365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4167","BTCY"],"gpt_icon":0},{"id":"2452476894","title":"Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV","url":"https://stock-news.laohu8.com/highlight/detail?id=2452476894","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452476894?lang=en_us&edition=fundamental","pubTime":"2024-07-19 21:00","pubTimestamp":1721394000,"startTime":"0","endTime":"0","summary":"ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd.  and Biotricity, Inc.  on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern Time . Bloomberg TV is available in an estimated 73 million homes across the U.S.Biotricity is transforming the healthcare market by bridging the gap in remote monitoring and chronic care management with a focus on cardiology. Physicians and patients trust Biotricity's unparalleled standard for preventive and personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com and follow us on Twitter and LinkedIn.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_CGqlr_T72W08fVAOQ9fAw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/e0cfc5cb7f676adb9179054efe7f38b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_CGqlr_T72W08fVAOQ9fAw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/e0cfc5cb7f676adb9179054efe7f38b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/enlivex-therapeutics-biotricity-interviews-air-130000162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TM","BTCY","ENLV","BK4585","BK4561","BK4100","LENZ","BK4167","BK4187","BK4099","BK4590","BK4581","ET","BK4144","TV","BK4139","AIRI","BK4555","BK4588","03160"],"gpt_icon":0},{"id":"2452192334","title":"SWK Holdings Highlights Recent Achievements and Provides Portfolio Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2452192334","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452192334?lang=en_us&edition=fundamental","pubTime":"2024-07-18 04:15","pubTimestamp":1721247300,"startTime":"0","endTime":"0","summary":"DALLAS, TX / ACCESSWIRE / July 17, 2024 / SWK Holdings Corporation  , a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower portfolio companies.\"During the second quarter we advanced capital to two existing borrowers and are working towards an additional closing in the next month,\" said SWK President and CEO Jody Staggs.\"Importantly, several of our borrower partners took advantage of the strong capital markets to raise equity or other forms of non-dilutive financing. We also repurchased $1 million of stock during the quarter and in July welcomed Adam Rice, CPA as our new Chief Financial Officer.\". SWK anticipates reporting second quarter 2024 results on Thursday, August 15 and will hold a conference call on Friday, August 16.AOTI, Inc.Advanced Oxygen Therapeutics, Inc.  is a medical technology company that develops and markets propri","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/BVNU1C2hBGyXl5nyCO116g--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/ef663a9ad7cde7ebdf63e3a9f9e3d02d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/BVNU1C2hBGyXl5nyCO116g--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/ef663a9ad7cde7ebdf63e3a9f9e3d02d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/swk-holdings-highlights-recent-achievements-201500482.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIOL","BK4167","TQQQ","QLD","PSQ","LU0321505439.SGD","QQQ","ELUT","DERM","SQQQ","BK4164","BK4566","LU0321505868.SGD","SWKH","BK4082","BK4588","BK4139","ETON","BK4007","MNQmain","QID","NQmain","BK4585","SWK","BTCY","BK4161",".IXIC"],"gpt_icon":0},{"id":"2450535714","title":"Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV","url":"https://stock-news.laohu8.com/highlight/detail?id=2450535714","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450535714?lang=en_us&edition=fundamental","pubTime":"2024-07-12 21:35","pubTimestamp":1720791300,"startTime":"0","endTime":"0","summary":"ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc.  and bioAffinity Technologies, Inc.  on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV, this Saturday, July 13, at 7 p.m. Eastern Time . Bloomberg TV is available in an estimated 73 million homes across the U.S.Biotricity is transforming the healthcare market by bridging the gap in remote monitoring and chronic care management with a focus on cardiology. Physicians and patients trust Biotricity's unparalleled standard for preventive and personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medica","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_CGqlr_T72W08fVAOQ9fAw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/e0cfc5cb7f676adb9179054efe7f38b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_CGqlr_T72W08fVAOQ9fAw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/e0cfc5cb7f676adb9179054efe7f38b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotricity-bioaffinity-technologies-interviews-air-133500636.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIAFW","TV","BK4139","BK4581","BK4555","BK4099","BK4561","BK4588","BIAF","AIRI","BK4585","BTCY","BK4144","TM","ET","03160","BK4590","BK4187","BK4100"],"gpt_icon":0},{"id":"2450595163","title":"BRIEF-Biotricity Accelerated Timeline To Achieving EBITDA Positive","url":"https://stock-news.laohu8.com/highlight/detail?id=2450595163","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450595163?lang=en_us&edition=fundamental","pubTime":"2024-07-11 20:07","pubTimestamp":1720699631,"startTime":"0","endTime":"0","summary":"July 11 (Reuters) - Biotricity Inc   :   * BIOTRICITY INC - ACCELERATED TIMELINE TO ACHIEVING EBITDA POSITIVE   * BIOTRICITY INC - EXPECTS TO REACH EBITDA POSITIVE BEFORE END OF CALENDAR 2024Source text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTCY"],"gpt_icon":0},{"id":"2450355366","title":"Biotricity Inc - Expects to Reach Ebitda Positive Before End of Calendar 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2450355366","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450355366?lang=en_us&edition=fundamental","pubTime":"2024-07-11 19:32","pubTimestamp":1720697547,"startTime":"0","endTime":"0","summary":"Biotricity Inc - Expects to Reach Ebitda Positive Before End of Calendar 2024","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240711:nFWN3J30NG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BTCY","BK4167"],"gpt_icon":0},{"id":"2450068890","title":"Biotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2450068890","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450068890?lang=en_us&edition=fundamental","pubTime":"2024-07-10 21:20","pubTimestamp":1720617600,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, CA / ACCESSWIRE / July 10, 2024 / Biotricity Inc. , a Technology-as-a-Service  company operating in the remote cardiac monitor sector of consumer healthcare, today announced the launch of a new cardiac monitoring pilot program with a prominent hospital group encompassing 60 sites spread across multiple states.Biotricity's cardiac monitoring solution is the only three-channel connected solution in the world. This unique technology results in superior diagnostics, reduced patient risk, and enhanced workflow efficiency, providing improved clinical outcomes while lowering overall healthcare costs. Additionally, it significantly increases provider revenue by five times compared to existing solutions, making it an exceptional choice both clinically and financially.Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements, which involve assumptions and describe our future plans, stra","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/S7NoY4Fk4Y8XZNrkFk00fA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/6602915a7edb69618135560a83aca165","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/S7NoY4Fk4Y8XZNrkFk00fA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/6602915a7edb69618135560a83aca165"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotricity-adds-60-multi-state-132000354.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1883839398.USD","BTCY","LU0061475181.USD","BK4167","STT","IE0034235188.USD","BK4135","BK4585","BK4588"],"gpt_icon":0},{"id":"2447658768","title":"Biotricity Inc reports results for the quarter ended in March - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2447658768","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2447658768?lang=en_us&edition=fundamental","pubTime":"2024-06-29 05:01","pubTimestamp":1719608505,"startTime":"0","endTime":"0","summary":"* Biotricity Inc    reported a quarterly adjusted loss of 47 cents per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of -54 cents.  The lo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTCY"],"gpt_icon":0},{"id":"2446506997","title":"Biotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening Now Available","url":"https://stock-news.laohu8.com/highlight/detail?id=2446506997","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446506997?lang=en_us&edition=fundamental","pubTime":"2024-06-28 19:30","pubTimestamp":1719574200,"startTime":"0","endTime":"0","summary":"Democratizing cardiac health with convenient, rapid, and reliable results. REDWOOD CITY, CA / ACCESSWIRE / June 28, 2024 / Biotricity Inc. , a forerunning Technology-as-a-Service  company committed to disrupting the healthcare industry with cutting-edge medical and consumer diagnostic solutions, today announced its groundbreaking direct-to-consumer heart health screening service, HeartSecure, is now available for purchase online at HeartSecure.Heart disease remains the leading cause of death worldwide, with someone succumbing to cardiovascular disease  every 1.5 seconds. In the United States alone, 127 million adults have at least one risk factor for heart disease, contributing to one out of every three deaths. Traditional pathways for cardiac screening can involve wait times of up to two months for an appointment and even longer for test results. HeartSecure addresses these delays by providing immediate, at-home results, significantly improving accessibility and timeliness in cardiac ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/8HvMVDIfV6qUoYcaOaXgIA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/d0132c51d54797cd2a101cfd9f0a3951","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/8HvMVDIfV6qUoYcaOaXgIA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/d0132c51d54797cd2a101cfd9f0a3951"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotricity-launches-heartsecure-immediate-home-113000061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HBCP","BK4167","BK4195","BK4211","BTCY"],"gpt_icon":0},{"id":"2446355347","title":"Biotricity GAAP EPS of -$0.47, revenue of $3.2M in-line","url":"https://stock-news.laohu8.com/highlight/detail?id=2446355347","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446355347?lang=en_us&edition=fundamental","pubTime":"2024-06-27 21:45","pubTimestamp":1719495909,"startTime":"0","endTime":"0","summary":"Biotricity press release  (NASDAQ:BTCY): Q4  GAAP EPS of -$0.47.\nRevenue of $3.2M (+18.5% Y/Y) in-line.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4120071-biotricity-gaap-eps-of-0_47-revenue-of-3_2m-in-line","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["QID","BK4167","MNQmain","QLD","QQQ","BTCY",".IXIC","BTCmain","PSQ","TQQQ","NQmain","SQQQ","XBTmain"],"gpt_icon":0},{"id":"2446531018","title":"Biotricity Q4 2024 Adj EPS $(0.47) Misses $(0.36) Estimate, Sales $3.200M Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2446531018","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446531018?lang=en_us&edition=fundamental","pubTime":"2024-06-27 20:26","pubTimestamp":1719491190,"startTime":"0","endTime":"0","summary":"Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.36) by 30.56 percent.  The company reported quarterly sales of $3.200 million which met the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/06/39523167/biotricity-q4-2024-adj-eps-0-47-misses-0-36-estimate-sales-3-200m-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTCY"],"gpt_icon":0},{"id":"2446953132","title":"Biotricity Q4 Revenue $3.2M, Up 15.9% YoY, EPS $(0.47)","url":"https://stock-news.laohu8.com/highlight/detail?id=2446953132","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446953132?lang=en_us&edition=fundamental","pubTime":"2024-06-27 20:19","pubTimestamp":1719490795,"startTime":"0","endTime":"0","summary":"Biotricity Q4 Revenue $3.2M, Up 15.9% YoY, EPS $(0.47)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/06/39523052/biotricity-q4-revenue-3-2m-up-15-9-yoy-eps-0-47","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTCY"],"gpt_icon":0},{"id":"2446531890","title":"Biotricity Q4 Gross Margin 71.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446531890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446531890?lang=en_us&edition=fundamental","pubTime":"2024-06-27 20:16","pubTimestamp":1719490577,"startTime":"0","endTime":"0","summary":"Biotricity Q4 Gross Margin 71.5%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240627:nPLX12E6B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","BTCY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biotricity.com","stockEarnings":[{"period":"1week","weight":0.0364},{"period":"1month","weight":-0.0339},{"period":"3month","weight":-0.0339},{"period":"6month","weight":-0.3372},{"period":"1year","weight":-0.6225},{"period":"ytd","weight":0.1875}],"description":"Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.","exchange":"OTCQB","name":"Biotricity Inc.","nameEN":"Biotricity Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biotricity Inc.(BTCY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biotricity Inc.(BTCY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biotricity Inc.,BTCY,Biotricity Inc.股票,Biotricity Inc.股票老虎,Biotricity Inc.股票老虎国际,Biotricity Inc.行情,Biotricity Inc.股票行情,Biotricity Inc.股价,Biotricity Inc.股市,Biotricity Inc.股票价格,Biotricity Inc.股票交易,Biotricity Inc.股票购买,Biotricity Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biotricity Inc.(BTCY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biotricity Inc.(BTCY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction